The NP said that the data room team would be bidding, this is obviously someone who has been negotiating for a longer time, as it is increasingly recognized how useful CCR5 inhibitors can be, all BP will want to have something like that, in my opinion if Bayer does not have their CCR5 inhibitor then they are very likely candidates for me to offer a partnership for a non-HIV program or something more, but after such publicly disclosed information Gilead has little time to decide if a CCR5 inhibitor is important to them , this is going to be very interesting time ahead of us.